Wellgistics Health, Inc. (WGRX) Stock Analysis
DELISTED 2026
What happened to Wellgistics Health, Inc. (WGRX) stock?
Wellgistics Health, Inc. (WGRX) no longer trades on public markets. It was delisted in July 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Wellgistics Health, Inc. (WGRX) trades at $3.52. Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products, serving pharmaceutical manufacturers and independent retail pharmacies in the United States. Market cap: $8.67M, Sector: Healthcare.
Last analyzed: May 10, 2026Analyst Coverage for WGRX: WGRX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WGRX against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
WGRX: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Wellgistics Health, Inc. (WGRX) Healthcare & Pipeline Overview
Wellgistics Health, Inc. distributes pharmaceutical products and provides third-party logistics within the U.S. healthcare sector. The company's DelivMeds platform offers clinical concierge services, targeting independent pharmacies and pharmaceutical manufacturers. Despite a challenging profit margin, Wellgistics aims to streamline pharmaceutical distribution and enhance pharmacy support services.
What Is the Investment Thesis for WGRX?
Wellgistics Health, Inc. presents a high-risk, high-reward investment profile. The company's negative profit margin of -433.9% and gross margin of -41.3% indicate significant operational challenges. However, its focus on independent pharmacies and pharmaceutical manufacturers, coupled with its DelivMeds platform, positions it to potentially capitalize on the growing demand for efficient pharmaceutical distribution and clinical support services. The company's small market capitalization of $8.67M suggests substantial growth potential if it can achieve operational efficiencies and expand its market share. Key to its success will be leveraging its third-party logistics services and the DelivMeds platform to drive revenue growth and improve profitability. Investors should closely monitor the company's ability to manage costs and achieve sustainable profitability in the competitive pharmaceutical distribution market.
Based on FMP financials and quantitative analysis
WGRX Key Highlights
Market capitalization of $8.67M, indicating a micro-cap company with high growth potential but also significant risk.
- Negative profit margin of -433.9%, reflecting substantial operational inefficiencies and challenges to profitability.
- Negative gross margin of -41.3%, suggesting that the cost of goods sold exceeds revenue, requiring significant improvements in pricing and cost management.
- Beta of -3.78, indicating an inverse correlation with the market, which may offer diversification benefits but also reflects unique company-specific risks.
- No dividend yield, consistent with a growth-oriented company focused on reinvesting earnings to expand its operations and market presence.
Who Are WGRX's Competitors?
WGRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| PDRX PD-Rx Pharmaceuticals, Inc. | $3.35 | +0.00% | $5.75M | 44 |
| CQCQ MakingORG, Inc. | $0.75 | +0.00% | $26.7M | 61 |
| HX Akso Health Group | $2.24 | -4.27% | $53.4M | 38 |
| GEG Great Elm Group, Inc. | $2.15 | +0.00% | $67.4M | — |
| ACH Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company | $1.31 | -0.76% | $100M | — |
| RDGT Ridgetech Inc. | $0.81 | -0.69% | 45 | |
| OMI Owens & Minor, Inc. | $2.68 | +8.94% | $207M | 44 |
| ZRSEF DocMorris AG | $10.24 | +0.00% | $500M | 41 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WGRX's Key Strengths?
DelivMeds platform offering clinical concierge services.
- Third-party logistics services tailored to pharmaceutical manufacturers.
- Distribution network of independent retail pharmacies.
- Focus on underserved markets.
What Are WGRX's Weaknesses?
Negative profit and gross margins.
- Small market capitalization.
- Limited brand recognition.
- High dependence on a niche market.
What Could Drive WGRX Stock Higher?
Expansion of the DelivMeds platform to include additional clinical services by Q4 2026.
- Strategic partnerships with pharmaceutical manufacturers to expand logistics services.
- Geographic expansion into new regions within the United States.
What Are the Key Risks for WGRX?
Financial-distress signal — its Altman Z-Score of -12.70 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Increased competition from established pharmaceutical distributors.
- Changes in pharmaceutical regulations affecting distribution practices.
- Negative profit and gross margins impacting financial stability.
- Economic downturn affecting healthcare spending.
What Are the Growth Opportunities for WGRX?
- Expansion of DelivMeds Platform: The DelivMeds platform offers a significant growth opportunity by providing clinical concierge services and streamlining prescription transfers for independent pharmacies. By expanding the platform's reach and functionality, Wellgistics can attract more pharmacies to its network and increase its revenue streams. The market for pharmacy support services is estimated to grow to $10 billion by 2030, presenting a substantial opportunity for Wellgistics to capture a significant share.
- Strategic Partnerships with Pharmaceutical Manufacturers: Collaborating with small and mid-size pharmaceutical manufacturers to provide comprehensive logistics solutions can drive revenue growth. By offering warehousing, inventory management, and shipping services, Wellgistics can become an integral part of the manufacturers' supply chain, securing long-term contracts and recurring revenue. The market for pharmaceutical logistics is projected to reach $150 billion by 2028, offering ample opportunities for Wellgistics to expand its service offerings.
- Geographic Expansion within the United States: Expanding its distribution network to new regions within the United States can increase Wellgistics' market reach and customer base. By targeting underserved markets with a high concentration of independent pharmacies, the company can establish a strong presence and capture market share. The U.S. pharmaceutical market is the largest in the world, providing a vast landscape for geographic expansion and revenue growth.
- Acquisition of Complementary Businesses: Acquiring smaller companies that offer complementary services, such as specialty pharmacy solutions or healthcare technology platforms, can enhance Wellgistics' capabilities and market position. Strategic acquisitions can provide access to new technologies, customer segments, and geographic markets, accelerating the company's growth trajectory. The healthcare M&A market remains active, presenting opportunities for Wellgistics to pursue accretive acquisitions.
- Development of Value-Added Services: Offering additional value-added services, such as data analytics, regulatory compliance support, and marketing assistance, can differentiate Wellgistics from its competitors and attract more customers. By providing comprehensive solutions that address the evolving needs of independent pharmacies and pharmaceutical manufacturers, the company can strengthen its customer relationships and increase its revenue per customer. The market for value-added services in the pharmaceutical industry is growing rapidly, driven by increasing regulatory complexity and the need for data-driven decision-making.
What Are WGRX's Competitive Advantages?
- DelivMeds Platform: The DelivMeds platform provides a unique service offering, creating a sticky customer base among independent pharmacies.
- Third-Party Logistics Expertise: Specialized logistics services for pharmaceutical manufacturers offer a competitive advantage.
- Established Distribution Network: A network of pharmacies and manufacturers provides a barrier to entry for new competitors.
What Does WGRX Do?
Wellgistics Health, Inc., formerly known as Danam Health, Inc., was incorporated in 2022 and is headquartered in Tampa, Florida. The company underwent a name change in October 2024 to better reflect its evolving business strategy. Wellgistics operates as a wholesaler and distributor of a wide array of pharmaceutical products, including both generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. These products are distributed to pharmaceutical manufacturers and independent retail pharmacies across the United States. In addition to its core distribution services, Wellgistics offers comprehensive third-party logistics solutions. These services encompass warehousing, inventory management, pick and pack operations, and shipping, tailored to meet the needs of small and mid-size pharmaceutical manufacturers. This end-to-end logistics support enables manufacturers to focus on their core competencies while ensuring efficient and reliable product delivery. A key component of Wellgistics' offering is the DelivMeds platform, designed as a pharmaceutical hub. This platform facilitates the seamless transfer of prescriptions and provides backend clinical concierge services to a network of independent pharmacies. By streamlining prescription management and offering clinical support, DelivMeds aims to enhance the operational efficiency and service quality of its pharmacy partners. Wellgistics also operates a retail community specialty, further expanding its reach within the pharmaceutical ecosystem.
What Products and Services Does WGRX Offer?
- Wholesales and distributes generic and branded pharmaceuticals.
- Distributes over-the-counter healthcare and consumer products.
- Provides third-party logistics services, including warehousing and inventory management.
- Offers pick and pack services for pharmaceutical products.
- Manages shipping and delivery to small and mid-size pharmaceutical manufacturers.
- Operates the DelivMeds platform, a pharmaceutical hub.
- Facilitates prescription transfers through the DelivMeds platform.
- Provides backend clinical concierge services to independent pharmacies.
How Does WGRX Make Money?
- Generates revenue through the wholesale distribution of pharmaceutical products.
- Earns fees for providing third-party logistics services to pharmaceutical manufacturers.
- Monetizes the DelivMeds platform by charging fees for prescription transfers and clinical concierge services.
What Industry Does WGRX Operate In?
The pharmaceutical distribution industry is characterized by intense competition and stringent regulatory requirements. Major players dominate the market, but there is a growing demand for specialized services catering to independent pharmacies and smaller pharmaceutical manufacturers. Wellgistics Health, Inc. operates in this niche, leveraging its DelivMeds platform and third-party logistics services to differentiate itself. The industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and advancements in pharmaceutical research and development. Wellgistics aims to capitalize on these trends by providing efficient and reliable distribution solutions to its target market.
Who Are WGRX's Key Customers?
- Independent retail pharmacies across the United States.
- Small and mid-size pharmaceutical manufacturers.
- Healthcare providers utilizing the DelivMeds platform.
Company Profile
Wellgistics Health, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Tampa, US. The company is led by CEO Prashant Patel. WGRX has traded publicly since 2025.
Wellgistics Health, Inc. (WGRX) Valuation Context
Valued at $8.67M, WGRX is classified as a micro-cap stock.
Financial Health
Wellgistics Health, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -12.70 places it in the distress zone, a signal of elevated financial risk.
WGRX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that those closest to the business believe in its potential.
- Social sentiment has shifted positively, with community discussions highlighting the company's innovative approaches in the health sector.
- Increased media coverage has spotlighted Wellgistics Health's unique solutions, fostering a more favorable public perception.
- Recent partnerships with health organizations have strengthened its market position, suggesting growth opportunities ahead.
Bear Case
- Concerns about regulatory challenges in the health sector have emerged, leading to skepticism about the company's operational stability.
- Community sentiment has shown some volatility, with mixed opinions on the company's long-term viability amid competition.
- Recent earnings reports have raised questions about profitability, causing some investors to reassess their positions.
- Market perception remains cautious due to broader economic uncertainties impacting the healthcare industry as a whole.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WGRX Latest News
-
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga · Jul 21, 2026
Leadership: Prashant Patel
CEO
Prashant Patel serves as the CEO of Wellgistics Health, Inc. His background includes experience in healthcare management and pharmaceutical distribution. Patel has a proven track record of driving growth and innovation in the healthcare sector. He brings a wealth of knowledge in supply chain management, regulatory compliance, and strategic planning to Wellgistics. His leadership is focused on expanding the company's market presence and enhancing its service offerings to meet the evolving needs of its customers.
Track Record: Under Prashant Patel's leadership, Wellgistics Health, Inc. has focused on developing the DelivMeds platform and expanding its third-party logistics services. He has overseen the company's rebranding efforts and strategic shift towards serving independent pharmacies and pharmaceutical manufacturers. Patel's key achievements include establishing partnerships with key industry players and driving innovation in pharmaceutical distribution.
Common Questions About WGRX (Healthcare)
What happened to Wellgistics Health, Inc. (WGRX) stock?
Wellgistics Health, Inc. (WGRX) no longer trades on public markets. It was delisted in July 2026. The figures below are historical and are not a current quote.
Can I still buy WGRX shares?
No. WGRX stopped trading on public markets in July 2026, so the shares are not available through a broker. Anything you see quoted for WGRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before WGRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Wellgistics Health, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Wellgistics Health, Inc. do?
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products, catering to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes both generic and branded pharmaceuticals, along with over-the-counter healthcare products. Additionally, Wellgistics provides third-party logistics services, including warehousing, inventory management, and shipping.
What do analysts say about WGRX stock?
Given Wellgistics Health, Inc.'s micro-cap status and financial challenges, analyst coverage may be limited. However, key valuation metrics to consider include its price-to-sales ratio and potential for revenue growth. The company's success hinges on its ability to improve its profit margins and expand its market share within the competitive pharmaceutical distribution industry.
What are the main risks for WGRX?
Wellgistics Health, Inc. faces several key risks, including intense competition from established pharmaceutical distributors with greater resources and market share. The company's negative profit and gross margins pose a significant financial risk, requiring substantial improvements in operational efficiency and cost management. Changes in pharmaceutical regulations and pricing pressures could also negatively impact its business.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on limited publicly available information.
- Analyst coverage may be limited due to the company's micro-cap status.